| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Floor | 8 | 2021 | 138 | 2.640 |
Why?
|
| Uterine Prolapse | 23 | 2008 | 73 | 2.540 |
Why?
|
| Tuberculosis, Meningeal | 11 | 2021 | 45 | 1.530 |
Why?
|
| Gynecologic Surgical Procedures | 14 | 2020 | 336 | 1.300 |
Why?
|
| Urinary Incontinence, Stress | 16 | 2009 | 183 | 1.290 |
Why?
|
| Urinary Incontinence | 9 | 2018 | 496 | 1.180 |
Why?
|
| Aneurysm, False | 3 | 2018 | 276 | 0.920 |
Why?
|
| Pelvic Organ Prolapse | 6 | 2020 | 135 | 0.900 |
Why?
|
| Surgical Mesh | 5 | 2012 | 276 | 0.830 |
Why?
|
| Rectocele | 8 | 2008 | 22 | 0.790 |
Why?
|
| Urogenital Surgical Procedures | 7 | 2007 | 35 | 0.750 |
Why?
|
| Exercise Therapy | 2 | 2018 | 906 | 0.740 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 2018 | 20 | 0.650 |
Why?
|
| Blood Preservation | 1 | 2018 | 177 | 0.620 |
Why?
|
| Conversion Disorder | 1 | 2021 | 205 | 0.610 |
Why?
|
| Vagina | 11 | 2016 | 825 | 0.600 |
Why?
|
| Leprosy, Borderline | 1 | 2016 | 4 | 0.590 |
Why?
|
| Fecal Incontinence | 2 | 2018 | 239 | 0.590 |
Why?
|
| Single-Chain Antibodies | 4 | 2022 | 108 | 0.560 |
Why?
|
| Obstetric Labor Complications | 1 | 2018 | 238 | 0.560 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 459 | 0.550 |
Why?
|
| Laparoscopy | 11 | 2020 | 2151 | 0.550 |
Why?
|
| Hypersplenism | 1 | 2015 | 5 | 0.530 |
Why?
|
| Abscess | 2 | 2016 | 607 | 0.520 |
Why?
|
| Splenic Artery | 1 | 2015 | 54 | 0.510 |
Why?
|
| Hysterectomy, Vaginal | 2 | 2005 | 37 | 0.510 |
Why?
|
| Postpartum Hemorrhage | 1 | 2018 | 258 | 0.510 |
Why?
|
| Skin Transplantation | 4 | 2008 | 1074 | 0.490 |
Why?
|
| Lipid Bilayers | 2 | 2006 | 381 | 0.480 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 565 | 0.470 |
Why?
|
| Microarray Analysis | 2 | 2007 | 767 | 0.460 |
Why?
|
| LEOPARD Syndrome | 1 | 2013 | 14 | 0.450 |
Why?
|
| Urinary Bladder Diseases | 5 | 2006 | 166 | 0.440 |
Why?
|
| Blood Transfusion | 2 | 2018 | 1301 | 0.440 |
Why?
|
| Rectovaginal Fistula | 2 | 2004 | 11 | 0.430 |
Why?
|
| Antibodies | 2 | 2020 | 2460 | 0.430 |
Why?
|
| Antibodies, Bispecific | 4 | 2019 | 164 | 0.430 |
Why?
|
| Subacute Sclerosing Panencephalitis | 1 | 2011 | 24 | 0.400 |
Why?
|
| Receptor, erbB-3 | 4 | 2013 | 142 | 0.390 |
Why?
|
| Medical Receptionists | 1 | 2010 | 2 | 0.380 |
Why?
|
| Nanostructures | 2 | 2007 | 551 | 0.380 |
Why?
|
| Polymers | 3 | 2007 | 1621 | 0.380 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2013 | 272 | 0.380 |
Why?
|
| Diaphragmatic Eventration | 1 | 2010 | 4 | 0.380 |
Why?
|
| Stomach Volvulus | 1 | 2010 | 6 | 0.380 |
Why?
|
| Antibodies, Monoclonal | 8 | 2019 | 9274 | 0.370 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2022 | 127 | 0.370 |
Why?
|
| Biosensing Techniques | 3 | 2007 | 668 | 0.360 |
Why?
|
| Aneurysm, Ruptured | 1 | 2015 | 452 | 0.360 |
Why?
|
| Marketing of Health Services | 1 | 2010 | 153 | 0.340 |
Why?
|
| Tic Disorders | 1 | 2010 | 127 | 0.340 |
Why?
|
| Embolization, Therapeutic | 2 | 2018 | 1392 | 0.340 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2010 | 114 | 0.330 |
Why?
|
| Practice Management, Medical | 1 | 2010 | 196 | 0.320 |
Why?
|
| Enzymes, Immobilized | 2 | 2007 | 48 | 0.320 |
Why?
|
| Prosthesis Implantation | 2 | 2012 | 642 | 0.320 |
Why?
|
| Dendrimers | 2 | 2007 | 68 | 0.320 |
Why?
|
| Trigeminal Nerve | 1 | 2010 | 249 | 0.320 |
Why?
|
| Community-Acquired Infections | 2 | 2022 | 465 | 0.300 |
Why?
|
| Nylons | 1 | 2007 | 47 | 0.300 |
Why?
|
| Facial Nerve | 1 | 2010 | 271 | 0.300 |
Why?
|
| Urodynamics | 6 | 2009 | 347 | 0.300 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2007 | 98 | 0.290 |
Why?
|
| Nanocomposites | 1 | 2007 | 52 | 0.290 |
Why?
|
| Telephone | 1 | 2010 | 617 | 0.290 |
Why?
|
| Albendazole | 3 | 2020 | 33 | 0.290 |
Why?
|
| Nanoparticles | 4 | 2022 | 1905 | 0.290 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2007 | 149 | 0.280 |
Why?
|
| Gold | 2 | 2007 | 484 | 0.280 |
Why?
|
| India | 10 | 2021 | 2197 | 0.270 |
Why?
|
| Electronics | 2 | 2007 | 322 | 0.270 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 1622 | 0.270 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2018 | 205 | 0.270 |
Why?
|
| Brain Stem | 1 | 2011 | 846 | 0.260 |
Why?
|
| Sutures | 2 | 1998 | 299 | 0.260 |
Why?
|
| Electrolytes | 1 | 2006 | 282 | 0.260 |
Why?
|
| Neurocysticercosis | 2 | 2020 | 62 | 0.260 |
Why?
|
| Vaginal Diseases | 3 | 2002 | 102 | 0.260 |
Why?
|
| Aorta | 1 | 2013 | 2061 | 0.250 |
Why?
|
| Liposomes | 2 | 2019 | 759 | 0.250 |
Why?
|
| Humans | 115 | 2023 | 744343 | 0.240 |
Why?
|
| Urination Disorders | 2 | 2002 | 241 | 0.240 |
Why?
|
| Female | 89 | 2021 | 380194 | 0.240 |
Why?
|
| Hysteroscopy | 1 | 2004 | 102 | 0.230 |
Why?
|
| Tuberculoma | 5 | 2016 | 14 | 0.230 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15540 | 0.220 |
Why?
|
| Radiography, Thoracic | 3 | 2018 | 1265 | 0.220 |
Why?
|
| Phospholipids | 1 | 2006 | 784 | 0.220 |
Why?
|
| BCG Vaccine | 1 | 2005 | 369 | 0.220 |
Why?
|
| Membranes | 1 | 2022 | 173 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 35421 | 0.210 |
Why?
|
| Electromyography | 2 | 2018 | 1379 | 0.210 |
Why?
|
| Adsorption | 2 | 2017 | 201 | 0.210 |
Why?
|
| Receptor, EphA2 | 2 | 2019 | 42 | 0.210 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2017 | 1572 | 0.210 |
Why?
|
| Spinal Nerve Roots | 1 | 2002 | 121 | 0.200 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 1375 | 0.200 |
Why?
|
| Durapatite | 1 | 2022 | 161 | 0.200 |
Why?
|
| Immunoconjugates | 2 | 2020 | 901 | 0.200 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2018 | 1442 | 0.200 |
Why?
|
| Pelvis | 2 | 2003 | 730 | 0.200 |
Why?
|
| Amnion | 1 | 2022 | 209 | 0.200 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2013 | 390 | 0.190 |
Why?
|
| Protein Engineering | 3 | 2016 | 540 | 0.190 |
Why?
|
| Tissue Transplantation | 1 | 2001 | 130 | 0.190 |
Why?
|
| Cicatrix | 2 | 2022 | 764 | 0.190 |
Why?
|
| Cysticercus | 1 | 2020 | 2 | 0.190 |
Why?
|
| Anthelmintics | 2 | 2020 | 62 | 0.190 |
Why?
|
| Hematoma | 1 | 2005 | 758 | 0.190 |
Why?
|
| Heart Ventricles | 1 | 2013 | 3821 | 0.180 |
Why?
|
| Treatment Outcome | 22 | 2020 | 63114 | 0.180 |
Why?
|
| Pelvic Pain | 1 | 2021 | 274 | 0.170 |
Why?
|
| Hospitals, University | 2 | 2014 | 571 | 0.170 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 1998 | 28 | 0.160 |
Why?
|
| Hematocrit | 1 | 2000 | 636 | 0.160 |
Why?
|
| Enbucrilate | 1 | 2018 | 31 | 0.160 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2018 | 60 | 0.160 |
Why?
|
| Protein Stability | 2 | 2017 | 557 | 0.160 |
Why?
|
| Hydrocephalus | 2 | 2016 | 748 | 0.160 |
Why?
|
| Pneumococcal Infections | 1 | 2022 | 497 | 0.160 |
Why?
|
| Antitubercular Agents | 4 | 2020 | 1320 | 0.160 |
Why?
|
| Suture Techniques | 4 | 2012 | 798 | 0.150 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2019 | 270 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2019 | 3557 | 0.150 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2019 | 357 | 0.150 |
Why?
|
| Prospective Studies | 18 | 2022 | 53288 | 0.150 |
Why?
|
| Ephrin-A2 | 1 | 2016 | 25 | 0.150 |
Why?
|
| Phlebography | 1 | 2018 | 333 | 0.150 |
Why?
|
| Cerebral Veins | 1 | 2018 | 156 | 0.150 |
Why?
|
| Parenting | 1 | 2023 | 679 | 0.150 |
Why?
|
| Pneumonia | 2 | 2020 | 2133 | 0.150 |
Why?
|
| Eclampsia | 1 | 2017 | 58 | 0.140 |
Why?
|
| Arachnoiditis | 1 | 2016 | 9 | 0.140 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2017 | 53 | 0.140 |
Why?
|
| Abnormalities, Multiple | 2 | 2012 | 1416 | 0.140 |
Why?
|
| Chromatography, Gel | 1 | 2017 | 668 | 0.140 |
Why?
|
| Osteosclerosis | 1 | 1996 | 39 | 0.140 |
Why?
|
| Endometritis | 1 | 1996 | 48 | 0.140 |
Why?
|
| Electric Stimulation Therapy | 1 | 2002 | 605 | 0.140 |
Why?
|
| Middle Aged | 46 | 2021 | 213383 | 0.140 |
Why?
|
| Renal Artery | 1 | 2018 | 398 | 0.140 |
Why?
|
| Biofeedback, Psychology | 1 | 2016 | 115 | 0.140 |
Why?
|
| Cyanosis | 2 | 2013 | 83 | 0.140 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 724 | 0.130 |
Why?
|
| Copper | 1 | 2018 | 366 | 0.130 |
Why?
|
| Thorax | 1 | 2018 | 547 | 0.130 |
Why?
|
| Adult | 39 | 2021 | 214055 | 0.130 |
Why?
|
| Hemostatics | 1 | 2018 | 229 | 0.130 |
Why?
|
| Child, Preschool | 14 | 2021 | 41006 | 0.130 |
Why?
|
| Bone Diseases, Developmental | 1 | 1996 | 130 | 0.130 |
Why?
|
| Infant | 12 | 2021 | 35136 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2019 | 578 | 0.130 |
Why?
|
| Antibody Specificity | 1 | 2017 | 1095 | 0.120 |
Why?
|
| Male | 35 | 2021 | 350118 | 0.120 |
Why?
|
| Pain | 1 | 2010 | 4986 | 0.120 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2016 | 274 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2002 | 1387 | 0.120 |
Why?
|
| Drug Delivery Systems | 2 | 2016 | 2219 | 0.120 |
Why?
|
| Cytotoxins | 1 | 2015 | 153 | 0.120 |
Why?
|
| Mice, SCID | 5 | 2020 | 2716 | 0.120 |
Why?
|
| Surgical Flaps | 1 | 2003 | 1640 | 0.120 |
Why?
|
| Leprosy, Tuberculoid | 1 | 2013 | 15 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2018 | 20129 | 0.120 |
Why?
|
| Neuritis | 1 | 2013 | 36 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1276 | 0.110 |
Why?
|
| Vaccination | 1 | 2005 | 3278 | 0.110 |
Why?
|
| Adolescent | 22 | 2021 | 85781 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1850 | 0.110 |
Why?
|
| Software | 2 | 2018 | 4443 | 0.110 |
Why?
|
| Leprosy | 1 | 2013 | 124 | 0.110 |
Why?
|
| Surgery Department, Hospital | 1 | 2014 | 175 | 0.110 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 2016 | 0.110 |
Why?
|
| Spinal Diseases | 1 | 2017 | 538 | 0.110 |
Why?
|
| Vascular Fistula | 1 | 2012 | 50 | 0.110 |
Why?
|
| Urologic Surgical Procedures | 2 | 2009 | 302 | 0.110 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2018 | 810 | 0.100 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2013 | 183 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 2557 | 0.100 |
Why?
|
| Suburethral Slings | 1 | 2012 | 76 | 0.100 |
Why?
|
| Arterio-Arterial Fistula | 1 | 2011 | 19 | 0.100 |
Why?
|
| World Health Organization | 1 | 2017 | 1318 | 0.100 |
Why?
|
| Pain Measurement | 1 | 2021 | 3420 | 0.100 |
Why?
|
| Syndrome | 2 | 2015 | 3251 | 0.100 |
Why?
|
| Oral Health | 1 | 2016 | 472 | 0.100 |
Why?
|
| Health Literacy | 1 | 2016 | 414 | 0.100 |
Why?
|
| Aged | 30 | 2021 | 163280 | 0.100 |
Why?
|
| Pineal Gland | 1 | 1992 | 166 | 0.100 |
Why?
|
| Neuregulin-1 | 1 | 2012 | 142 | 0.100 |
Why?
|
| Child | 20 | 2023 | 77709 | 0.100 |
Why?
|
| Anticestodal Agents | 1 | 2010 | 3 | 0.090 |
Why?
|
| Device Approval | 1 | 2012 | 163 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 2017 | 760 | 0.090 |
Why?
|
| Drug Design | 2 | 2013 | 1076 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 6622 | 0.090 |
Why?
|
| Situs Inversus | 1 | 2010 | 64 | 0.090 |
Why?
|
| Patient Satisfaction | 3 | 2016 | 3396 | 0.090 |
Why?
|
| Home Care Services | 1 | 2016 | 606 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 1236 | 0.090 |
Why?
|
| Vaccines, Conjugate | 2 | 2022 | 333 | 0.090 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 804 | 0.090 |
Why?
|
| Proteins | 1 | 2004 | 6103 | 0.090 |
Why?
|
| Parents | 1 | 2023 | 3407 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2007 | 2699 | 0.090 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2012 | 317 | 0.080 |
Why?
|
| Ligaments | 3 | 2005 | 128 | 0.080 |
Why?
|
| Urinary Tract | 3 | 2001 | 309 | 0.080 |
Why?
|
| Vestibular Diseases | 1 | 2011 | 217 | 0.080 |
Why?
|
| Colpotomy | 1 | 2008 | 14 | 0.080 |
Why?
|
| Equipment Design | 1 | 2016 | 3582 | 0.080 |
Why?
|
| Cell Line, Tumor | 7 | 2020 | 16689 | 0.080 |
Why?
|
| Pancreatitis | 1 | 2015 | 1092 | 0.080 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 3610 | 0.080 |
Why?
|
| Thermoanaerobacter | 1 | 2007 | 1 | 0.080 |
Why?
|
| L-Iditol 2-Dehydrogenase | 1 | 2007 | 5 | 0.080 |
Why?
|
| Granuloma | 1 | 2010 | 319 | 0.080 |
Why?
|
| Conductometry | 1 | 2007 | 9 | 0.080 |
Why?
|
| Butyrylcholinesterase | 1 | 2007 | 22 | 0.080 |
Why?
|
| Valerates | 1 | 2007 | 21 | 0.080 |
Why?
|
| Hysterectomy | 3 | 2000 | 927 | 0.080 |
Why?
|
| Inservice Training | 1 | 2010 | 392 | 0.080 |
Why?
|
| Phenylacetates | 1 | 2007 | 114 | 0.080 |
Why?
|
| Tuberculosis | 1 | 2020 | 1912 | 0.070 |
Why?
|
| Psychometrics | 1 | 2016 | 3002 | 0.070 |
Why?
|
| Acetylcholinesterase | 1 | 2007 | 153 | 0.070 |
Why?
|
| Lung Transplantation | 1 | 2016 | 1153 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 3772 | 0.070 |
Why?
|
| Cystocele | 1 | 2006 | 5 | 0.070 |
Why?
|
| Polyamines | 1 | 2007 | 120 | 0.070 |
Why?
|
| Electrochemistry | 1 | 2006 | 145 | 0.070 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2007 | 119 | 0.070 |
Why?
|
| Quartz | 1 | 2006 | 24 | 0.070 |
Why?
|
| Robotics | 1 | 2014 | 899 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2019 | 10481 | 0.070 |
Why?
|
| Colloids | 1 | 2006 | 136 | 0.070 |
Why?
|
| Pneumococcal Vaccines | 2 | 2022 | 391 | 0.070 |
Why?
|
| Diagnosis, Differential | 5 | 2017 | 12959 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2013 | 2938 | 0.070 |
Why?
|
| Appointments and Schedules | 1 | 2010 | 417 | 0.070 |
Why?
|
| Mice, Inbred NOD | 3 | 2019 | 1878 | 0.070 |
Why?
|
| Angiography | 1 | 2012 | 1639 | 0.070 |
Why?
|
| Prosthesis Failure | 1 | 2011 | 1206 | 0.070 |
Why?
|
| Models, Structural | 1 | 2006 | 361 | 0.070 |
Why?
|
| Solutions | 1 | 2006 | 426 | 0.070 |
Why?
|
| Postoperative Complications | 8 | 2020 | 15295 | 0.070 |
Why?
|
| Antigens | 1 | 2012 | 1466 | 0.070 |
Why?
|
| Cohort Studies | 4 | 2021 | 40561 | 0.070 |
Why?
|
| Young Adult | 11 | 2021 | 56430 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4479 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2737 | 0.070 |
Why?
|
| Follow-Up Studies | 10 | 2020 | 39050 | 0.070 |
Why?
|
| Pyrazinamide | 1 | 2005 | 54 | 0.070 |
Why?
|
| Signal Transduction | 4 | 2019 | 23403 | 0.070 |
Why?
|
| Anemia | 1 | 2015 | 1506 | 0.070 |
Why?
|
| Private Practice | 1 | 2006 | 154 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2006 | 563 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 6234 | 0.060 |
Why?
|
| Microchemistry | 1 | 2004 | 57 | 0.060 |
Why?
|
| Heart Atria | 1 | 2011 | 1357 | 0.060 |
Why?
|
| Dyspnea | 1 | 2013 | 1303 | 0.060 |
Why?
|
| Electrodes | 1 | 2007 | 619 | 0.060 |
Why?
|
| Hernia | 2 | 2002 | 71 | 0.060 |
Why?
|
| Catalytic Domain | 1 | 2007 | 698 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 964 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 3327 | 0.060 |
Why?
|
| Alcoholism | 1 | 2015 | 1906 | 0.060 |
Why?
|
| Acute Disease | 1 | 2015 | 7149 | 0.060 |
Why?
|
| Respiration | 1 | 2011 | 1653 | 0.060 |
Why?
|
| Injections, Intramuscular | 1 | 2005 | 552 | 0.060 |
Why?
|
| Isoniazid | 1 | 2005 | 274 | 0.060 |
Why?
|
| Pregnancy | 5 | 2018 | 29144 | 0.060 |
Why?
|
| Rifampin | 1 | 2005 | 315 | 0.060 |
Why?
|
| Social Behavior | 1 | 2010 | 1127 | 0.060 |
Why?
|
| Neoplasms | 5 | 2020 | 21683 | 0.060 |
Why?
|
| Transplantation, Homologous | 3 | 2002 | 4776 | 0.060 |
Why?
|
| Warfarin | 1 | 2012 | 1496 | 0.060 |
Why?
|
| Retrospective Studies | 15 | 2020 | 77449 | 0.060 |
Why?
|
| Taxoids | 2 | 2019 | 666 | 0.060 |
Why?
|
| Calcinosis | 1 | 1992 | 1499 | 0.060 |
Why?
|
| Child Rearing | 1 | 2023 | 74 | 0.060 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 1876 | 0.050 |
Why?
|
| Animals | 14 | 2020 | 168757 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2004 | 292 | 0.050 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 14722 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 2866 | 0.050 |
Why?
|
| Fluorescence | 1 | 2004 | 751 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 1456 | 0.050 |
Why?
|
| Receptor, erbB-2 | 1 | 2012 | 2416 | 0.050 |
Why?
|
| Vasospasm, Intracranial | 1 | 2004 | 208 | 0.050 |
Why?
|
| Dyspareunia | 1 | 2002 | 50 | 0.050 |
Why?
|
| Surface Properties | 1 | 2004 | 1184 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2006 | 1899 | 0.050 |
Why?
|
| Organ Preservation | 1 | 2004 | 331 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2015 | 5179 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5974 | 0.050 |
Why?
|
| Urination | 1 | 2002 | 204 | 0.050 |
Why?
|
| Tumor Burden | 2 | 2019 | 1915 | 0.050 |
Why?
|
| Transplantation, Heterologous | 2 | 2009 | 2382 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7279 | 0.050 |
Why?
|
| Prolapse | 1 | 2000 | 68 | 0.050 |
Why?
|
| Dermis | 1 | 2002 | 207 | 0.050 |
Why?
|
| Cell Line | 1 | 2015 | 15997 | 0.050 |
Why?
|
| Digoxin | 1 | 1981 | 250 | 0.040 |
Why?
|
| Incidence | 6 | 2016 | 20947 | 0.040 |
Why?
|
| Uterus | 1 | 2004 | 711 | 0.040 |
Why?
|
| Sacrum | 1 | 2002 | 288 | 0.040 |
Why?
|
| Genital Diseases, Female | 1 | 2001 | 197 | 0.040 |
Why?
|
| Disulfides | 1 | 2022 | 457 | 0.040 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2022 | 482 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2005 | 1125 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2013 | 5985 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2010 | 2708 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2012 | 2788 | 0.040 |
Why?
|
| Meningoencephalitis | 1 | 1999 | 78 | 0.040 |
Why?
|
| Recurrence | 6 | 2002 | 8340 | 0.040 |
Why?
|
| Seizures | 3 | 2020 | 2859 | 0.040 |
Why?
|
| Aged, 80 and over | 11 | 2018 | 57776 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2020 | 841 | 0.040 |
Why?
|
| Echinococcosis, Pulmonary | 1 | 1998 | 7 | 0.040 |
Why?
|
| Abdomen | 2 | 2009 | 1118 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2023 | 747 | 0.040 |
Why?
|
| Wounds, Penetrating | 1 | 2000 | 307 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 3507 | 0.040 |
Why?
|
| Postoperative Period | 2 | 2001 | 1842 | 0.040 |
Why?
|
| Fundus Oculi | 1 | 1999 | 473 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2012 | 6196 | 0.040 |
Why?
|
| Developing Countries | 1 | 2010 | 2815 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 2278 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 13695 | 0.040 |
Why?
|
| Materials Testing | 1 | 2001 | 867 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2002 | 824 | 0.040 |
Why?
|
| Thoracic Diseases | 1 | 1998 | 97 | 0.040 |
Why?
|
| Brain Diseases | 3 | 1992 | 1563 | 0.040 |
Why?
|
| Videotape Recording | 1 | 1998 | 352 | 0.040 |
Why?
|
| Epitopes | 2 | 2015 | 2571 | 0.040 |
Why?
|
| Rectum | 1 | 2002 | 904 | 0.040 |
Why?
|
| Cystoscopy | 1 | 1997 | 134 | 0.040 |
Why?
|
| Pelvic Bones | 1 | 1999 | 265 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2012 | 4599 | 0.040 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2002 | 576 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2006 | 5456 | 0.030 |
Why?
|
| Suppuration | 1 | 1996 | 56 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2004 | 1018 | 0.030 |
Why?
|
| Minnesota | 1 | 2016 | 344 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2013 | 3689 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 1999 | 275 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2020 | 693 | 0.030 |
Why?
|
| Anticonvulsants | 2 | 2020 | 1916 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2011 | 6150 | 0.030 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 1996 | 65 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2016 | 421 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 6489 | 0.030 |
Why?
|
| Optic Atrophy | 1 | 1996 | 79 | 0.030 |
Why?
|
| Decision Trees | 1 | 2017 | 506 | 0.030 |
Why?
|
| Ligands | 2 | 2015 | 3282 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1997 | 362 | 0.030 |
Why?
|
| Epilepsy, Generalized | 1 | 1997 | 174 | 0.030 |
Why?
|
| Mice | 6 | 2020 | 81183 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2019 | 2327 | 0.030 |
Why?
|
| Intraoperative Complications | 2 | 2003 | 1198 | 0.030 |
Why?
|
| Cadaver | 1 | 1999 | 1337 | 0.030 |
Why?
|
| Meningitis | 1 | 1996 | 216 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5097 | 0.030 |
Why?
|
| Protein Binding | 3 | 2012 | 9386 | 0.030 |
Why?
|
| Swine | 1 | 2004 | 5917 | 0.030 |
Why?
|
| Reoperation | 3 | 2002 | 4201 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 2018 | 885 | 0.030 |
Why?
|
| Needles | 1 | 1996 | 449 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 3848 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 15076 | 0.030 |
Why?
|
| Antibodies, Neoplasm | 1 | 2015 | 286 | 0.030 |
Why?
|
| Brain | 6 | 2020 | 26385 | 0.030 |
Why?
|
| Outpatients | 1 | 2020 | 1486 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2004 | 23338 | 0.030 |
Why?
|
| Gynecology | 1 | 1998 | 513 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2023 | 8324 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2008 | 3158 | 0.030 |
Why?
|
| Cranial Nerve Diseases | 1 | 2013 | 112 | 0.030 |
Why?
|
| Encephalitis, Japanese | 1 | 1992 | 12 | 0.030 |
Why?
|
| Tacrolimus | 1 | 2016 | 743 | 0.030 |
Why?
|
| Length of Stay | 2 | 2007 | 6309 | 0.030 |
Why?
|
| Headache | 1 | 2020 | 1226 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 2727 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2006 | 2861 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2001 | 2240 | 0.030 |
Why?
|
| Deafness | 1 | 1996 | 458 | 0.030 |
Why?
|
| Papilledema | 1 | 2013 | 118 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1997 | 1681 | 0.030 |
Why?
|
| ROC Curve | 1 | 1999 | 3527 | 0.030 |
Why?
|
| Binding Sites, Antibody | 1 | 2012 | 349 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2000 | 2250 | 0.020 |
Why?
|
| Skull | 1 | 1996 | 813 | 0.020 |
Why?
|
| Collagen | 1 | 2000 | 2689 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 2645 | 0.020 |
Why?
|
| Age Distribution | 2 | 2007 | 2902 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 1996 | 608 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 6487 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2012 | 254 | 0.020 |
Why?
|
| Cricetulus | 1 | 2013 | 816 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 459 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1855 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1981 | 2268 | 0.020 |
Why?
|
| Teaching | 1 | 1998 | 1174 | 0.020 |
Why?
|
| Graft Survival | 1 | 2001 | 3737 | 0.020 |
Why?
|
| Infant, Newborn | 4 | 2017 | 25625 | 0.020 |
Why?
|
| Inhalation | 1 | 2011 | 143 | 0.020 |
Why?
|
| Ambulances | 1 | 2011 | 95 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2023 | 3188 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6386 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18029 | 0.020 |
Why?
|
| CHO Cells | 1 | 2013 | 1406 | 0.020 |
Why?
|
| Gene Library | 1 | 2013 | 1074 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 1791 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 463 | 0.020 |
Why?
|
| Sacrococcygeal Region | 1 | 2009 | 52 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1999 | 6459 | 0.020 |
Why?
|
| Femur | 1 | 1996 | 1297 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2013 | 826 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2003 | 2758 | 0.020 |
Why?
|
| Urinary Bladder | 2 | 2009 | 1172 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 1832 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 9981 | 0.020 |
Why?
|
| Health Surveys | 2 | 2010 | 4037 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1970 | 0.020 |
Why?
|
| Inpatients | 1 | 2020 | 2518 | 0.020 |
Why?
|
| Prognosis | 3 | 2016 | 29063 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3952 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2012 | 2408 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2022 | 5317 | 0.020 |
Why?
|
| Hemoglobins, Abnormal | 1 | 1989 | 119 | 0.020 |
Why?
|
| Radiography | 1 | 2020 | 7023 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5524 | 0.020 |
Why?
|
| Cervix Uteri | 1 | 2012 | 590 | 0.020 |
Why?
|
| Comorbidity | 2 | 2016 | 10388 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 2170 | 0.020 |
Why?
|
| Hand | 1 | 2013 | 884 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1526 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 2541 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 19905 | 0.020 |
Why?
|
| Polyethyleneimine | 1 | 2007 | 63 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2007 | 210 | 0.020 |
Why?
|
| Coenzymes | 1 | 2007 | 91 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 944 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 2795 | 0.020 |
Why?
|
| Algorithms | 2 | 2010 | 13881 | 0.020 |
Why?
|
| NADP | 1 | 2007 | 226 | 0.020 |
Why?
|
| United States | 6 | 2011 | 69872 | 0.020 |
Why?
|
| Sirolimus | 1 | 2013 | 1564 | 0.020 |
Why?
|
| Epilepsies, Partial | 1 | 1990 | 436 | 0.020 |
Why?
|
| Prevalence | 3 | 2008 | 15226 | 0.020 |
Why?
|
| Automobile Driving | 1 | 2011 | 431 | 0.020 |
Why?
|
| Age Factors | 3 | 2007 | 18370 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2011 | 687 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2013 | 1058 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 977 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1119 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 2503 | 0.020 |
Why?
|
| Quality of Life | 3 | 2003 | 12804 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2109 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 6473 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3843 | 0.010 |
Why?
|
| Genetics, Population | 1 | 1989 | 934 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2011 | 1584 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4204 | 0.010 |
Why?
|
| NAD | 1 | 2007 | 593 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2007 | 729 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2017 | 5102 | 0.010 |
Why?
|
| Middle Cerebral Artery | 1 | 2004 | 264 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12245 | 0.010 |
Why?
|
| Sex Factors | 1 | 2016 | 10397 | 0.010 |
Why?
|
| Polypropylenes | 1 | 2002 | 64 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4933 | 0.010 |
Why?
|
| HIV Infections | 2 | 2020 | 16718 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 21827 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1981 | 230 | 0.010 |
Why?
|
| Time Factors | 3 | 2016 | 40075 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2004 | 1423 | 0.010 |
Why?
|
| Retreatment | 1 | 2002 | 610 | 0.010 |
Why?
|
| Echocardiography | 1 | 2012 | 5102 | 0.010 |
Why?
|
| Pelvimetry | 1 | 1999 | 6 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13284 | 0.010 |
Why?
|
| Risk Factors | 4 | 2010 | 72290 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2011 | 4577 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9727 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1981 | 1420 | 0.010 |
Why?
|
| Phenotype | 1 | 1996 | 16365 | 0.010 |
Why?
|
| Fascia | 1 | 1998 | 135 | 0.010 |
Why?
|
| Audiovisual Aids | 1 | 1998 | 92 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2009 | 8436 | 0.010 |
Why?
|
| Urethra | 1 | 2000 | 408 | 0.010 |
Why?
|
| Cystoscopes | 1 | 1997 | 5 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2007 | 2616 | 0.010 |
Why?
|
| Data Collection | 1 | 2006 | 3341 | 0.010 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1999 | 360 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2010 | 12026 | 0.010 |
Why?
|
| Dogs | 1 | 1981 | 3912 | 0.010 |
Why?
|
| Research Design | 1 | 2012 | 5987 | 0.010 |
Why?
|
| Parity | 1 | 1999 | 929 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1999 | 783 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 1999 | 530 | 0.010 |
Why?
|
| Medical Records | 1 | 1999 | 1413 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 12788 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11524 | 0.010 |
Why?
|
| Educational Measurement | 1 | 1998 | 1210 | 0.010 |
Why?
|
| Catheterization | 1 | 1997 | 1470 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1998 | 1547 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 1996 | 1011 | 0.010 |
Why?
|
| Education, Medical, Undergraduate | 1 | 1998 | 1008 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 25043 | 0.010 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1989 | 16 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 17446 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1997 | 9849 | 0.000 |
Why?
|
| Internship and Residency | 1 | 1998 | 5788 | 0.000 |
Why?
|